Transmembrane TNF-α, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease

This publication has 25 references indexed in Scilit:

• Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease
  Gut, 2001
• Remission of Behçet's syndrome with tumour necrosis factor α blocking therapy
  Annals of the Rheumatic Diseases, 2001
• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
  Science, 1998
• Death Receptors: Signaling and Modulation
  Science, 1998
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
  New England Journal of Medicine, 1997
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
  Cell, 1996
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
  Science, 1996
• Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
  Cytokine, 1995
• The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation.
  The Journal of Experimental Medicine, 1993